Professor Danny Rischin is the Director of Medical Oncology at the Peter MacCallum Cancer Centre. A highly productive clinician‐researcher, he has made significant and sustained contributions to advancing knowledge and in developing new therapies for head and neck cancer and cutaneous squamous cell carcinoma.

Professor Rischin is an international leader in head and neck cancer, with his work having had a significant impact on clinical practice. In his leadership roles in co-operative clinical trials groups and as Director of a pre-eminent medical oncology department he has mentored and supervised many successful clinician‐researchers.